12:00 AM
May 17, 2010
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

RXi Pharmaceuticals preclinical data

In mice, sd-rxRNA compounds displayed "robust" uptake in retinal cells and led to significant target gene silencing following local administration compared to conventional siRNA compounds....

Read the full 101 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >